Laxminarayana Burela

About

Specialization:
Postdoctoral Training @ Greenebaum Cancer Centre, Univ. of Maryland: Cell Culture
Postdoctoral Training @ National Institutes of Health: Molecular Biology
Doctoral Training @ University of Hyderabad: Biochemistry
Master’s Training @ Sri Sathya Sai Institute of Higher Learning: Bioscience

I am a self-motivated, determined and trained in India and United States of America. I have 16 plus years of Post Ph. D. experience in academia and industry. I prefer to apply and in fact applied in the past, the multidisciplinary/integrative approach, applying the skills of Biochemistry, Cell & Molecular Biology and Microbiology to study Translational control and developing recombinant protein based products. I am specialized in establishing, managing laboratories & project management and teaching activities. I have a proven track record of teaching graduate and postgraduate students in life sciences/biotechnology. I was a team player and team leader, one who strongly believes in team efforts. I work towards the sustainable and harmonious growth of myself and my organization.

Employment

• Aurora Associate Professor
  2022 - Present
• ATGC Biotech Private Limited Consultant
  2019 - 2020
• Revelations Biotech Private Limited Staff Scientist
  2017 - 2018
• Shubhra Biotech Private Limited Chief Scientist
  2013 - 2016
• Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Postdoctoral Research Fellow
  2010 - 2011
• Sreenidhi Institute of Science and Technology Faculty
  2008 - 2009
• Sudarshan Biotech Private Limited Scientist
  2007 - 2008
• National Institutes of Health Visiting Fellow - Postdoctoral Research Fellow
  2003 - 2006

Education

• University of Hyderabad Ph. D.
  1997 - 2002
• Sri Sathya Sai Institute of Higher Learning M. Sc. Bioscience - Gold Medalist
  1994 - 1996

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Biosynthesis of recombinant proteins in yeast expression platform, Pichia.
  Antarmukha Research Journal 2022
  +Save
• The C-Terminal Region of Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes mRNA Recruitment, Scanning, and, Together with eIF3j and the eIF3b RNA Recognition Motif, Selection of AUG Start Codons
  Molecular and Cellular Biology 2010 DOI: 10.1128/mcb.00280-10
  +Save
• Trends in wheat germ cell free protein expression system with an emphasis on up-scaling and industrial application
  Indian Journal of Science and Technology 2010 DOI: 10.17485/ijst/2010/v3i3/29716
  +Save
• eIF3a cooperates with sequences 5′ of uORF1 to promote resumption of scanning by post-termination ribosomes for reinitiation on GCN4 mRNA
  Genes & Development 2008 DOI: 10.1101/gad.480508
  +Save
• Evidence that association of eIF1 with the C-terminal domain of eIF3 subunit a/TIF32 is required for optimal binding of eIF2/GTP/Met-tRNAiMet ternary complexes to 40S ribosome in vivo.
  CSHL Translational Control 2004
  +Save
• Translation and Phosphorylation of Wheat Germ Lysate: Phosphorylation of Wheat Germ Initiation Factor 2 by Casein Kinase II and in N-Ethylmaleimide-Treated Lysates
  Archives of Biochemistry and Biophysics 2002 DOI: 10.1006/abbi.2002.2763
  +Save
• An improved process for the preparation of amines from azides
  2002
  +Save
• Biotransformations of 4-Methyl umbelliferone derivatives - Fungal mediated O-dealkylations
  Recent Advances In Basic and Applied Aspects of Industrial Catalysis, Proceedings of 13th National Symposium and Silver Jubilee Symposium of Catalysis of India 1998 DOI: 10.1016/s0167-2991(98)80329-7
  +Save
• Stereo and chemoselective enzymatic reduction of azido functionality: Synthesis of 4-β-aminopodophyllotoxin congeners by baker's yeast
  Tetrahedron Letters 1997 DOI: 10.1016/s0040-4039(97)01582-7
  +Save
• Novel biocatalytic reduction of aryl azides: chemoenzymatic synthesis of pyrrolo[2,1-c][1,4]benzodiazepine antibiotics1
  Chemical Communications 1997 DOI: 10.1039/a701249g
  +Save